Glipizide Impurity 13 | CAS 5521-55-1 - Request Quote
Glipizide Impurity 13
| SZ CAT No: | SZ-G009036 |
| CAS No | 5521-55-1 |
| Mol.F. | C6H6N2O2 |
| Mol.Wt. | 138.1 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 168423-75-4 (Sodium salt; 51037-39-9 (potassium salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Glipizide Impurity 13 is chemically 5-Methylpyrazine-2-carboxylic acid. Glipizide Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Glipizide Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Glipizide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 5521-55-1
Purchase 5521-55-1
Order 5521-55-1
Enquire 5521-55-1
price of 5521-55-1
5521-55-1 Supplier
5521-55-1 Manufacturer
5521-55-1 Exporter
buy high quality Glipizide Impurity 13
Purchase Glipizide Impurity 13
Glipizide Impurity 13 suppliers
Glipizide Impurity 13 manufacturers
Glipizide Impurity 13 price
Order Glipizide Impurity 13
Enquire Glipizide Impurity 13
Glipizide Impurity 13 cost
Glipizide Impurity 13 Supplier
Glipizide Impurity 13 Distributor
Glipizide Impurity 13 for Method Validation
Glipizide Reference Standard
Glipizide Impurity 13 for ANDA Filing
Glipizide Impurity 13 for Forced Degradation Studies
Glipizide Impurity 13 Identification Standards
Glipizide Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


